Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04715685 · ClinicalTrials.gov registry record · NA
Mind Body Balance for Pediatric Migraine
A NA study of Migraine and Headache, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 2
- Study locations
NCT04715685: Recruiting NA study of Migraine and Headache, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT04715685 is a NA study of Migraine and Headache that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 260 participants, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (27% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04715685, a NA study of Migraine and Headache, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study uses a factorial research design to evaluate a nurse delivered mind body intervention using different doses of 3 treatment components to determine the optimized treatment for headache day reduction.
Primary Outcome
This outcomes measure examines whether the rate of absolute number of headache days, per 28 day period, differs between the treatment groups over time. This will be assessed longitudinally based on the actual number of headache days from the 28 days prior to randomization to the last 28 days before the endpoint visit.
Conditions Studied
Interventions
- BEHAVIORAL 40 minute session
- BEHAVIORAL 20 minute session
- BEHAVIORAL home practice e-health
- BEHAVIORAL home practice handout
- BEHAVIORAL phone call
Study Locations (2)
Colorado
- University of Colorado/Children's Hospital Colorado - Aurora
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2021-03-09 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT04715685 shows while recruiting
NCT04715685 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (27% lower).
The record links to 8 conditions, with Migraine appearing as the primary indexed condition, and to 5 interventions - of which 40 minute session is the first listed.
NCT04715685 reports a single indexed study location in Colorado, Ohio.
Frequently Asked Questions
What is clinical trial NCT04715685 about?
NCT04715685 is a clinical study titled "Mind Body Balance for Pediatric Migraine". This study uses a factorial research design to evaluate a nurse delivered mind body intervention using different doses of 3 treatment components to determine the optimized treatment for headache day reduction.
What is the current status of trial NCT04715685?
This trial is currently recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2021-03-09. Estimated completion is 2026-05-31.
What conditions does trial NCT04715685 study?
This clinical trial studies the following conditions: Migraine, Headache, Migraine Disorders, Chronic Migraine, Headache, Migraine.
What interventions are being tested in trial NCT04715685?
The interventions under investigation include: 40 minute session (BEHAVIORAL), 20 minute session (BEHAVIORAL), home practice e-health (BEHAVIORAL), home practice handout (BEHAVIORAL), phone call (BEHAVIORAL).
Who is sponsoring clinical trial NCT04715685?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04715685 being conducted?
This trial has 2 study locations across Colorado, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04715685's enrollment target sits among peer trials
260 35th of 102 higher than 68 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI